100+
paid subscribers
10K+
free subscribers

Vejon COVID-19 Review

About the Substack

Comprehensive overview of COVID-19 research by Dr Philip McMillan, focusing on autoimmunity as the primary pathology in the disease.

Free Subscription Benefits

  • Occasional public posts

Paid Subcription Benefits

  • Subscriber-only posts and full archive
  • Subscriber-only episodes in your podcast app
  • Post comments and join the community

Paid Subscription Plans

  • £60 a year
  • £6 a month

About Dr Philip McMillan

Physician and researcher with an innovative approach to COVID-19 and dementia reversal, international keynote speaker and LinkedIn Live influencer.

Is this your Substack? Request changes.

Vejon COVID-19 Review's recommended Substacks

Smith's Virology Blog logo
Jennifer Smith, PhD

Smith's Virology Blog

Sharing science based information to help educate and inform people on various topics of public health interest to assist in the fight to bring integrity and honesty back to medicine, science and public health.

1K+
free subscribers
Long Covid Analysed logo
Dr Philip McMillan

Long Covid Analysed

Research into multiple aspects of long Covid disease, explained in a way that makes it easier to understand.

3K+
free subscribers
Who is Robert Malone logo
Robert W Malone MD, MS

Who is Robert Malone

Politics, homesteading, medicine, science, bioethics, analytics, and a heady mix of sarcasm and life.

10K+
paid subscribers
341K+
free subscribers
Voice for Science and Solidarity by Geert Vanden Bossche logo
Geert Vanden Bossche

Voice for Science and Solidarity by Geert Vanden Bossche

Mass infection prevention and mass vaccination with leaky Covid-19 vaccines in the midst of the pandemic can only breed highly infectious variants.

100+
paid subscribers
31K+
free subscribers
INSIDE PHARMA logo
Hedley Rees

INSIDE PHARMA

This Substack is about education in the Pharma supply chain, so you can ask the killer questions. COVID only succeeded because people thought that drugs are found ‘by accident.’ They didn’t challenge the narrative of 100-day drugs. Now you can.

6K+
free subscribers